脳卒中管理の市場規模、シェア、成長分析、タイプ別、製品別、エンドユーザー別、地域別- 産業予測、2024～2031年

脳卒中管理の世界市場規模は、2022年に366億米ドルと評価され、2023年の393億8,000万米ドルから2031年には707億6,000万米ドルに成長し、予測期間中（2024～2031年）のCAGRは7.6％で成長する見通しです。

世界の脳卒中管理市場は、急速な高齢化とともに、医療技術の進歩や診断・治療方法の強化に後押しされ、大きな成長を遂げています。遠隔医療とデジタルヘルスソリューションの統合により、脳卒中治療へのアクセスが改善される一方、予防的戦略と包括的なリハビリテーションプログラムが重視されています。市場の主要企業は、血栓回収装置、神経保護剤、個別化治療アプローチなどの分野で技術革新を進めています。しかしながら、特に発展途上地域における脳卒中治療へのアクセスや認知度の格差など、課題は依然として残っています。市場は、転帰の改善と脳卒中の長期的影響の軽減を目指した進行中の研究に支えられながら、患者中心の統合ケアモデルへと進化しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

脳卒中管理の市場規模：タイプ別& CAGR（2024-2031）

• 市場概要
• 虚血性
• 出血性
• 一過性脳虚血発作（TIA）
• その他

脳卒中管理の市場規模：製品別& CAGR（2024-2031）

• 市場概要
• 診断装置
  • 磁気共鳴画像（MRI）
  • コンピュータ断層撮影スキャン（CTスキャン）
  • 心電図検査
  • 頸動脈超音波検査
  • 脳血管造影検査
  • その他
• 治療機器
  • ステントレトリーバー
  • 外科用クリップ
  • 塞栓コイル
  • フローダイバーター
  • 吸引カテーテル
  • その他

脳卒中管理の市場規模：エンドユーザー別& CAGR（2024-2031）

• 市場概要
• 病院
• 診断クリニック
• 外来手術センター
• その他

脳卒中管理の市場規模：地域別& CAGR（2024-2031）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021-2023）

主要企業プロファイル

• Medtronic
• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Boston Scientific Corporation
• Abbott Laboratories
• Johnson & Johnson
• Penumbra, Inc.
• Stryker Corporation
• Boehringer Ingelheim
• AstraZeneca
• Pfizer Inc.
• Sanofi
• Bayer AG
• Daiichi Sankyo Company, Limited
• F. Hoffmann-La Roche Ltd
• Teva Pharmaceuticals
• Lupin Pharmaceuticals
• Fresenius SE & Co. KGaA
• Amneal Pharmaceuticals LLC

結論と推奨事項

Global Stroke Management Market size was valued at USD 36.6 billion in 2022 and is poised to grow from USD 39.38 billion in 2023 to USD 70.76 billion by 2031, growing at a CAGR of 7.6% during the forecast period (2024-2031).

The global stroke management market is witnessing significant growth, propelled by advancements in medical technology and enhanced diagnosis and treatment methods, alongside a rapidly aging population. The integration of telemedicine and digital health solutions is improving access to stroke care, while there is a strong emphasis on preventive strategies and comprehensive rehabilitation programs. Key market players are innovating in areas such as clot retrieval devices, neuroprotective agents, and personalized treatment approaches. Nonetheless, challenges persist, particularly regarding disparities in stroke care access and awareness in developing regions. The market is evolving towards integrated, patient-centric care models, supported by ongoing research aimed at improving outcomes and reducing long-term effects of strokes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stroke Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Stroke Management Market Segmental Analysis

Global Stroke Management Market is segmented by type, product, end user and region. Based on type, the market is segmented into ischemic, hemorrhagic, transient ischemic attack (TIA) and others. Based on product, the market is segmented into diagnostic devices and therapeutic devices. Based on end user, the market is segmented into hospitals, diagnostic clinics, ambulatory surgery centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Stroke Management Market

The global stroke management market is experiencing significant growth driven by several key factors. One of the primary catalysts is the rising investment in healthcare infrastructure, which supports the implementation of cutting-edge technologies and telemedicine solutions. These advancements facilitate earlier diagnoses and more effective treatment options, significantly enhancing the quality of care provided to stroke patients. As healthcare systems evolve and prioritize these innovative approaches, patient outcomes are improved, leading to a greater demand for comprehensive stroke management solutions. Consequently, the market is expected to expand as healthcare providers increasingly adopt these transformative tools to optimize patient care.

Restraints in the Global Stroke Management Market

The global stroke management market faces several significant restraints that impede its growth potential. A notable barrier is the lack of accessibility to effective stroke care, particularly in underserved regions where awareness of stroke symptoms and treatment options remains low. Additionally, the high cost of treatment poses a financial challenge for many patients, further limiting their access to necessary interventions. Moreover, the integration of advanced stroke management technologies within existing healthcare systems often encounters obstacles, preventing seamless implementation and optimal utilization. These factors collectively hinder the advancement and expansion of stroke management solutions on a global scale.

Market Trends of the Global Stroke Management Market

The global stroke management market is experiencing significant growth, driven by technological advancements and increased awareness. Telemedicine and digital health innovations facilitate timely remote monitoring and intervention, drastically improving patient care. Enhanced neuroimaging techniques, like MRI and CT scans, provide precise diagnoses, allowing for more accurate treatment plans. Minimally invasive surgical options, particularly endovascular thrombectomy, are transforming acute management strategies. Additionally, breakthroughs in pharmaceuticals have introduced more effective thrombolytics and neuroprotective agents. Collaborative research initiatives and heightened public awareness around early intervention and risk factor management underscore a concerted effort to enhance prevention, acute treatment, and rehabilitation, ultimately aiming to reduce the global burden of stroke.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Stroke Management Market Size by Type & CAGR (2024-2031)

• Market Overview
• Ischemic
• Hemorrhagic
• Transient Ischemic Attack (TIA)
• Others

Global Stroke Management Market Size by Product & CAGR (2024-2031)

• Market Overview
• Diagnostic Devices
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography Scan (CT scan)
  • Electrocardiography
  • Carotid Ultrasound
  • Cerebral Angiography
  • Others
• Therapeutic Devices
  • Stent Retriever
  • Surgical Clips
  • Embolic Coils
  • Flow Diverters
  • Aspiration Catheters
  • Others

Global Stroke Management Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals
• Diagnostic Clinics
• Ambulatory Surgery Centers
• Others

Global Stroke Management Market Size & CAGR (2024-2031)

• North America (Type, Product, End User)
  • USA
  • Canada
• Europe (Type, Product, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daiichi Sankyo Company, Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amneal Pharmaceuticals LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations